Company: HSDTW
Filing Date: 2025-01-31
Form Type: S-3
Source: 0001104659-25-008126
Chunk: 2

Company: Solana Co
Filing Date: 2025-01-31
Form: S-3
Chunk 2
---

**This prospectus relates to the resale by the selling stockholders named herein, or their pledgees, donees, transferees or other successors in interest, from time to time, of up to 6,213,888 shares of our Class A common stock (“common stock”) issuable upon exercise of warrants granted to certain investors in connection with warrant exercise inducement letters entered into on January 21, 2025. The shares of common stock issuable upon exercise of the warrants are referred to herein as the Securities. We are registering the Securities on behalf of the selling stockholders, to be offered and sold from time to time, to satisfy certain registration rights that we have granted to the selling stockholders.

The selling stockholders may resell or dispose of the Securities, or interests therein, at fixed prices, at prevailing market prices at the time of sale or at prices negotiated with purchasers, to or through underwriters, broker-dealers, agents, or through any other means described in the section of this prospectus entitled “Plan of Distribution”. The selling stockholders will each bear their respective commissions and discounts, if any, attributable to the sale or disposition of the Securities, or interests therein, held by such selling stockholder. We will bear all costs, expenses and fees in connection with the registration of the Securities. We will not receive any of the proceeds from the sale of the Securities by the selling stockholders.

Our common stock is listed on the Nasdaq Capital Market under the symbol “HSDT.” On January 30, 2025, the last reported sale price of our common stock on the Nasdaq Capital Market was $0.635 per share.

INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE “**

### RISK FACTORS
**” CONTAINED OR INCORPORATED BY REFERENCE IN THIS PROSPECTUS CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.**

#### The date of this prospectus is           , 2025.
TABLE OF CONTENTS

CONTENTS

| ​ | ABOUT THIS PROSPECTUS                             | ​ | ​ | ​ | ​ |  1 |